Apply to role >
πŸ“
Warsaw, Poland

Analyst, Clinical Trial Transparency, Anonymization (perm / fix term)

1 yrs
Health
Science
September 28, 2025

Astrazeneca

Global biopharmaceutical company
view website >

Location: Warsaw, Poland

Hybrid model of work: 3 days in office, 2 remote per week

‍

The Clinical Transparency & Data Sharing team is within CMO office and leads the AstraZeneca Group of Companies, Clinical Trial Transparency Position Globally. We are responsible for clinical data sharing, clinical document sharing and clinical transparency patient engagement activities such as the Lay Summaries and Thank you cards.

‍

The CTT Anonymization Analyst will process clinical study documents for anonymization and/or pseudo anonymization in support of Health Canada’s PRCI process, EMA policy 0070 and other disclosure of clinical documents that must be redacted or otherwise anonymized. The individual is accountable to anonymize submission clinical study documents and associated study data using the latest tools and industry best practices. This role will require an in-depth understanding of how AstraZeneca works to meet associated regulatory policies, privacy, clinical data and documents. The ideal candidate possesses the following:

‍

‍

This role will work globally with individual study teams to deliver anonymized documents for regulatory submission and data sharing. This role will NOT manage the submission; they will provide submission ready deliverables to regulatory submission teams.

‍

The role will be an individual contributor.

‍

The successful candidate role models AstraZeneca values and principles and encourages others to do so.

‍

Typical Accountabilities and required competencies:

‍

Education, Qualifications, Skills and Experience

Essential:

‍

Desirable:

‍